Teresa L. Young, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 59 shares at $16.65 ($982) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Scheduled sale ($982) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2025-05-19 | $459 | — | Filing → |
| MCRB | SELL | 2025-02-19 | $3K | — | Filing → |
| MCRB | SELL | 2024-11-19 | $397 | — | Filing → |